Abstract
High density lipoprotein (HDL) has two important roles: a) it modulates inflammation, and, b) it promotes reverse cholesterol transport. HDLcholesterol levels are inversely correlated with the risk of cardiovascular events. The main component of HDL, apolipoprotein AI (apo AI), is largely responsible for reverse cholesterol transport through the macrophage ATPbinding cassette transporter ABCA1. Apo AI can be damaged by oxidative mechanisms, which render the protein less able to promote cholesterol efflux. HDL also contains a number of other proteins that are affected by the oxidative environment of the acutephase response. Modification of the protein components of HDL can convert it from an antiinflammatory to a pro inflammatory and dysfunctional particle. Small peptides that mimic some of the properties of apo AI have been shown in preclinical models to improve HDL function and reduce atherosclerosis without altering HDLcholesterol levels. Endothelium is the interface between the blood and the extra vascular environment regulating the traffic of vital molecules between the blood and tissues. Oxidative stress and excess levels of reactive oxygen species disrupt the normal function of endothelium. HDL and other antioxidant/anti-inflammatory systems prevent endothelial dysfunction and maintain the critical balance needed for normal vascular function.
Keywords: Endothelium, HDL, inflammation, Ox-lipids, PON1, ROS.
Current Medicinal Chemistry
Title:Inflammation, High Density Lipoprotein and Endothelium
Volume: 21 Issue: 25
Author(s): Sepideh Madahian, Kaveh Daniel Navab, Nasim Pourtabatabaei, Seyedehsara Seyedali, Sheila Safar, Samra Vazirian and Greg Hough
Affiliation:
Keywords: Endothelium, HDL, inflammation, Ox-lipids, PON1, ROS.
Abstract: High density lipoprotein (HDL) has two important roles: a) it modulates inflammation, and, b) it promotes reverse cholesterol transport. HDLcholesterol levels are inversely correlated with the risk of cardiovascular events. The main component of HDL, apolipoprotein AI (apo AI), is largely responsible for reverse cholesterol transport through the macrophage ATPbinding cassette transporter ABCA1. Apo AI can be damaged by oxidative mechanisms, which render the protein less able to promote cholesterol efflux. HDL also contains a number of other proteins that are affected by the oxidative environment of the acutephase response. Modification of the protein components of HDL can convert it from an antiinflammatory to a pro inflammatory and dysfunctional particle. Small peptides that mimic some of the properties of apo AI have been shown in preclinical models to improve HDL function and reduce atherosclerosis without altering HDLcholesterol levels. Endothelium is the interface between the blood and the extra vascular environment regulating the traffic of vital molecules between the blood and tissues. Oxidative stress and excess levels of reactive oxygen species disrupt the normal function of endothelium. HDL and other antioxidant/anti-inflammatory systems prevent endothelial dysfunction and maintain the critical balance needed for normal vascular function.
Export Options
About this article
Cite this article as:
Madahian Sepideh, Navab Daniel Kaveh, Pourtabatabaei Nasim, Seyedali Seyedehsara, Safar Sheila, Vazirian Samra and Hough Greg, Inflammation, High Density Lipoprotein and Endothelium, Current Medicinal Chemistry 2014; 21 (25) . https://dx.doi.org/10.2174/0929867321666140414105530
DOI https://dx.doi.org/10.2174/0929867321666140414105530 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Use of Heat Shock Protein 70
Recent Patents on DNA & Gene Sequences Targeting Complement in Rheumatoid Arthritis
Current Rheumatology Reviews Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial
Current Vascular Pharmacology Longevity Pathways: HSF1 and FoxO Pathways, a New Therapeutic Target to Prevent Age-Related Diseases
Current Aging Science RAGE Isoforms, its Ligands and their Role in Pathophysiology of Alzheimer’s Disease
Current Alzheimer Research Modulation of Angiotensin-II and Angiotensin 1-7 Levels Influences Cardiac Function in Myocardial Ischemia-reperfusion Injury
Current Drug Research Reviews New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications
Current Radiopharmaceuticals HIV Infection, Antiretroviral Therapy Initiation and Longitudinal Changes in Biomarkers of Organ Function
Current HIV Research The Role of P2Y<sub>12</sub> Receptor and Activated Platelets During Inflammation
Current Drug Targets Carotid Baroreceptor Stimulation: A Promising Approach for the Management of Resistant Hypertension and Heart Failure
Current Vascular Pharmacology Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches
Current Medicinal Chemistry Exosomes: The Messengers of Health and Disease
Current Neuropharmacology An Umbrella Review of Nuts Intake and Risk of Cardiovascular Disease
Current Pharmaceutical Design Cell Death: Tipping the Balance of Autoimmunity and Tissue Repair
Current Pharmaceutical Design Caspases: Structure-Guided Design of Drugs to Control Cell Death
Mini-Reviews in Medicinal Chemistry Effect of Dietary Education on Cardiovascular Risk Factors in Rheumatoid Arthritis Patients
Current Rheumatology Reviews mRNA as a Therapeutic Target in Lung Disease
Drug Design Reviews - Online (Discontinued) Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases
Current Medicinal Chemistry Mitochondrial Dynamics: An Emerging Paradigm in Ischemia-Reperfusion Injury
Current Pharmaceutical Design Nutritional Deficiency in Early Life Facilitates Aging-Associated Cognitive Decline
Current Alzheimer Research